Investment Banking Medical Middle Market 
Focus Investment Banking
MAY 31, 2024
Further, National’s ability to collaborate with customer engineering teams during the design phase can help expedite the process of bringing new products to market and ensure leading product quality in terms of both performance and aesthetics. appeared first on FOCUS.
Focus Investment Banking
AUGUST 15, 2023
Washington, DC, (August 15, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that it has added two new managing directors, Mike McCraw and William R. Bill”) Snow.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Focus Investment Banking
NOVEMBER 30, 2023
They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. “We We enjoyed working with Eric Yetter and Andy Snyder at FOCUS Investment Banking, said Richard Strabbing, M.D., who serves as Michigan ENT’s managing partner.
Focus Investment Banking
JULY 20, 2023
Coining primarily serves the aerospace & defense, medical, electronics and semiconductor end markets for a variety of product types and applications, including microelectronic and sonic packages, sensors, implantable devices, connectors, terminals, solder cups, thermocouple pins and seal headers.
InvestmentBank.com
DECEMBER 1, 2020
M&A Beat – US Health Services Q2 2020 M&A Beat is a quarterly update for CEO’s, CFO’s, Owner, Founders of lower middle-market ($10M-$100M Rev) companies, offering relevant details on mergers and acquisitions deal value, volume, valuation multiples and trends in their respective industry and vertical. acquisition.
Mergers and Inquisitions
NOVEMBER 1, 2023
The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. They do not invest in risky biotech startups attempting to cure cancer (at least not within their traditional PE portfolios).
Tyton Partners
APRIL 10, 2024
Excolere Equity Partners is a leading middle market private equity firm that leverages its deep sector experience and strategic and operational expertise to accelerate the growth and enhance the impact of companies in the Education and Human Capital sector.
Expert insights. Personalized for you.
52 
Let's personalize your content